Prognostic value of noninvasive combined anatomic/functional assessment by cardiac CT in patients with suspected coronary artery disease — Comparison with invasive coronary angiography and nuclear myocardial perfusion imaging for the five-year-follow up of the CORE320 multicenter study

      Abstract

      Background

      Few data exist on long-term outcome in patients undergoing combined coronary CT angiography (CTA) and myocardial CT perfusion imaging (CTP) as well as invasive coronary angiography (ICA) and single photon emission tomography (SPECT).

      Methods

      At 16 centers, 381 patients were followed for major adverse cardiac events (MACE) for the CORE320 study. All patients underwent coronary CTA, CTP, and SPECT before ICA within 60 days. Prognostic performance according binary results (normal/abnormal) was assessed by 5-year major cardiovascular events (MACE) free survival and area under the receiver-operating-characteristic curve (AUC).

      Results

      Follow up beyond 2-years was available in 323 patients. MACE-free survival rate was greater among patients with normal combined CTA-CTP findings compared to ICA-SPECT: 85 vs. 80% (95% confidence interval [CI] for difference 0.1, 11.3) though event-free survival time was similar (4.54 vs. 4.37 years, 95% CI for difference: -0.03, 0.36). Abnormal results by combined CTA-CTP was associated with 3.83 years event-free survival vs. 3.66 years after abnormal combined ICA-SPECT (95% CI for difference: -0.05, 0.39). Predicting MACE by AUC also was similar: 65 vs. 65 (difference 0.1; 95% CI -4.6, 4.9). When MACE was restricted to cardiovascular death, myocardial infarction, or stroke, AUC for CTA-CTP was 71 vs. 60 by ICA-SPECT (difference 11.2; 95% CI -1.0, 19.7).

      Conclusions

      Combined CTA-CTP evaluation yields at least equal 5-year prognostic information as combined ICA-SPECT assessment in patients presenting with suspected coronary artery disease. Noninvasive cardiac CT assessment may eliminate the need for diagnostic cardiac catheterization in many patients.

      Clinical trial registration

      NCT00934037.

      Keywords

      To read this article in full you will need to make a payment

      References

        • Benjamin E.J.
        • Muntner P.
        • Alonso A.
        • et al.
        Heart disease and stroke statistics-2019 update: a report from the american heart association.
        Circulation. 2019; 139 ([doi]): e56-e528https://doi.org/10.1161/CIR.0000000000000659
        • Arbab-Zadeh A.
        • Fuster V.
        From detecting the vulnerable plaque to managing the vulnerable patient.
        J Am Coll Cardiol. 2019; 74: 1582-1593
        • Newby D.E.
        • Adamson P.D.
        • et al.
        • SCOT-HEART Investigators
        Coronary CT angiography and 5-year risk of myocardial infarction.
        N Engl J Med. 2018; 379: 924-933
        • Bittencourt M.S.
        • Hulten E.A.
        • Murthy V.L.
        • et al.
        Clinical outcomes after evaluation of stable chest pain by coronary computed tomographic angiography versus usual care: a meta-analysis.
        Circ Cardiovasc Imaging. 2016; 9e004419
        • Rochitte C.E.
        • George R.T.
        • Chen M.Y.
        • et al.
        Computed tomography angiography and perfusion to assess coronary artery stenosis causing perfusion defects by single photon emission computed tomography: the CORE320 study.
        Eur Heart J. 2014; 35: 1120-1130
        • Chen M.Y.
        • Rochitte C.E.
        • Arbab-Zadeh A.
        • et al.
        Prognostic value of combined CT angiography and myocardial perfusion imaging versus invasive coronary angiography and nuclear stress perfusion imaging in the prediction of major adverse cardiovascular events: the CORE320 multicenter study.
        Radiology. 2017; 284 ([doi]): 55-65https://doi.org/10.1148/radiol.2017161565
        • Vavere A.L.
        • Simon G.G.
        • George R.T.
        • et al.
        Diagnostic performance of combined noninvasive coronary angiography and myocardial perfusion imaging using 320 row detector computed tomography: design and implementation of the CORE320 multicenter, multinational diagnostic study.
        J Cardiovasc Comput Tomogr. 2011; 5: 370-381
        • George R.T.
        • Arbab-Zadeh A.
        • Cerci R.J.
        • et al.
        Diagnostic performance of combined noninvasive coronary angiography and myocardial perfusion imaging using 320-MDCT: the CT angiography and perfusion methods of the CORE320 multicenter multinational diagnostic study.
        AJR Am J Roentgenol. 2011; 197: 829-837
        • Cerci R.J.
        • Arbab-Zadeh A.
        • George R.T.
        • et al.
        Aligning coronary anatomy and myocardial perfusion territories: an algorithm for the CORE320 multicenter study.
        Circ Cardiovasc Imaging. 2012; 5: 587-595
        • Leaman D.M.
        • Brower R.W.
        • Meester G.T.
        • Serruys P.
        • van den Brand M.
        Coronary artery atherosclerosis: severity of the disease, severity of angina pectoris and compromised left ventricular function.
        Circulation. 1981; 63: 285-299
        • Chow S.
        • Shao J.
        • Wang H.
        Sample Size Calculations in Clinical Research.
        second ed. Chapman and Hall/CRC, Boca Raton2008
        • Virani S.S.
        • Alonso A.
        • Benjamin E.J.
        • et al.
        Heart disease and stroke statistics-2020 update: a report from the american heart association.
        Circulation. 2020; ([doi])CIR0000000000000757https://doi.org/10.1161/CIR.0000000000000757
        • Noto Tj J.
        • Johnson L.W.
        • Krone R.
        • et al.
        Cardiac catheterization 1990: a report of the registry of the society for cardiac angiography and interventions (SCA&I).
        Cathet Cardiovasc Diagn. 1991; 24: 75-83
        • Chang H.J.
        • Lin F.Y.
        • Gebow D.
        • et al.
        Selective referral using CCTA versus direct referral for individuals referred to invasive coronary angiography for suspected CAD: a randomized, controlled, open-label trial.
        JACC Cardiovasc Imaging. 2018; 12 (S1936-878X(18)30921-5 [pii]): 1303-1312
        • Haase R.
        • Schlattmann P.
        • Gueret P.
        • et al.
        Diagnosis of obstructive coronary artery disease using computed tomography angiography in patients with stable chest pain depending on clinical probability and in clinically important subgroups: meta-analysis of individual patient data.
        BMJ. 2019; 365: l1945https://doi.org/10.1136/bmj.l1945
        • Feuchtner G.
        • Loureiro R.
        • Bezerra H.
        • et al.
        Quantification of coronary stenosis by dual source computed tomography in patients: a comparative study with intravascular ultrasound and invasive angiography.
        Eur J Radiol. 2012; 81: 83-88
        • Budoff M.J.
        • Nakazato R.
        • Mancini G.B.
        • et al.
        Head-to-head comparison of quantitative coronary angiography, and computed tomography angiography for the prediction of hemodyanmic significance in intermediate and severe lesions, using fractional flow reserve as reference standard.
        JACC Cardiovasc.Imaging. 2016; 9: 559-564https://doi.org/10.1016/j.jcmg.2015.08.021
        • Napp A.E.
        • Haase R.
        • Laule M.
        • et al.
        Computed tomography versus invasive coronary angiography: design and methods of the pragmatic randomised multicentre DISCHARGE trial.
        Eur Radiol. 2017; 27 ([doi]): 2957-2968https://doi.org/10.1007/s00330-016-4620-z
        • Sharma A.
        • Arbab-Zadeh A.
        Assessment of coronary heart disease by CT angiography: current and evolving applications.
        J Nucl Cardiol. 2012; 19: 796-806
        • Arbab-Zadeh A.
        • Nakano M.
        • Virmani R.
        • Fuster V.
        Acute coronary events.
        Circulation. 2012; 125: 1147-1156
        • Arbab-Zadeh A.
        • Fuster V.
        The risk continuum of atherosclerosis and its implications for defining CHD by coronary angiography.
        J Am Coll Cardiol. 2016; 68: 2467-2478